News › Industry News, Patient Care

Makers of Ozempic and Mounjaro Sued over ‘Stomach Paralysis’ Claims

August 3, 2023

The drugmakers Novo Nordisk and Eli Lilly failed to adequately warn patients about the possible risk of severe stomach problems associated with their blockbuster drugs Ozempic and Mounjaro, according to a lawsuit filed Wednesday.

The 26-page lawsuit, filed on behalf of a Louisiana woman who says she was “severely injured” after taking the two diabetes drugs, is the first to allege that they can cause gastrointestinal injuries.

Read more at NBC News >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Acquisition Lets AI and Operators Learn From Nearly $2 Billion in Annual Aesthetics Transactions
    • Galderma Celebrates 30 Years of Restylane
    • FDA Issues Letter to Evolus Over Jeuveau Social Media Promotion
    • North Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Retatrutide Phase 3 Trial: Adults With Type 2 Diabetes Lost Average of 50 Pounds
Advertisement